Anevlavis Stavros, Petroglou Niki, Tzavaras Athanasios, Maltezos Efstratios, Pneumatikos Ioannis, Froudarakis Marios, Anevlavis Eleftherios, Bouros Demosthenes
Department of Pneumonology, Medical School, Democritus University of Thrace, Dragana, Alexandroupolis, Greece.
J Infect. 2009 Aug;59(2):83-9. doi: 10.1016/j.jinf.2009.05.011. Epub 2009 Jun 6.
Sputum Gram stain and culture have been said to be unreliable indicators of the microbiological diagnosis of bacterial pneumonia. The etiological diagnosis of pneumonia is surrounded by great degree of uncertainty. This uncertainty should be and can be calculated and incorporated in the diagnosis and treatment.
To determine the diagnostic accuracy and diagnostic value of sputum Gram stain in etiological diagnosis and initial selection of antimicrobial therapy of bacterial community acquired pneumonia (CAP). DESIGN-METHOD: Prospective study of 1390 patients with CAP admitted January 2002-June 2008, to our institutions. Of the 1390 patients, 178 (12.8%) fulfilled the criteria for inclusion into this study (good-quality sputa and presence of the same microorganism in blood and sputum cultures which was used as gold standard for assessing the diagnostic accuracy and diagnostic value of sputum Gram stain).
The sensitivity of sputum Gram stain was 0.82 for Pneumococcal pneumonia, 0.76 for Staphylococcal pneumonia, 0.79 for Haemophilus influenzae pneumonia and 0.78 for Gram-negative bacilli pneumonia. The specificity of sputum Gram stain was 0.93 for Pneumococcal pneumonia, 0.96 for Staphylococcal pneumonia, 0.96 for H. influenzae pneumonia and 0.95 for Gram-negative bacilli pneumonia. The positive likelihood ratio (LR+) was 11.58 for Pneumococcal pneumonia, 19.38 for Staphylococcal pneumonia, 16.84 for H. influenzae pneumonia, 14.26 for Gram-negative bacilli pneumonia. The negative likelihood ratio (LR-) was 0.20 for Pneumococcal pneumonia, 0.25 for Staphylococcal pneumonia, 0.22 for H. influenzae pneumonia, and 0.23 for Gram-negative bacilli pneumonia.
Sputum Gram stain is a dependable diagnostic test for the early etiological diagnosis of bacterial CAP that helps in choosing orthological and appropriate initial antimicrobial therapy.
痰革兰氏染色和培养一直被认为是细菌性肺炎微生物学诊断的不可靠指标。肺炎的病因诊断存在很大程度的不确定性。这种不确定性应该并且可以进行计算,并纳入诊断和治疗中。
确定痰革兰氏染色在细菌性社区获得性肺炎(CAP)的病因诊断和初始抗菌治疗选择中的诊断准确性和诊断价值。
对2002年1月至2008年6月入住我们机构的1390例CAP患者进行前瞻性研究。在这1390例患者中,178例(12.8%)符合本研究的纳入标准(高质量痰液以及血液和痰液培养中存在相同微生物,后者用作评估痰革兰氏染色诊断准确性和诊断价值的金标准)。
痰革兰氏染色对肺炎球菌肺炎的敏感性为0.82,对葡萄球菌肺炎为0.76,对流感嗜血杆菌肺炎为0.79,对革兰氏阴性杆菌肺炎为0.78。痰革兰氏染色对肺炎球菌肺炎的特异性为0.93,对葡萄球菌肺炎为0.96,对流感嗜血杆菌肺炎为0.96,对革兰氏阴性杆菌肺炎为0.95。肺炎球菌肺炎的阳性似然比(LR+)为11.58,葡萄球菌肺炎为19.38,流感嗜血杆菌肺炎为16.84,革兰氏阴性杆菌肺炎为14.26。肺炎球菌肺炎的阴性似然比(LR-)为0.20,葡萄球菌肺炎为0.25,流感嗜血杆菌肺炎为0.22,革兰氏阴性杆菌肺炎为0.23。
痰革兰氏染色是细菌性CAP早期病因诊断的可靠诊断试验,有助于选择正确且合适的初始抗菌治疗。